|
|
|
|
Y Funasaka, T Boulton, M Cobb, Y Yarden, B Fan, SD Lyman, DE Williams, DM Anderson, R Zakut and Y Mishima
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06510.
The proto-oncogene c-Kit, a transmembrane receptor tyrosine kinase, is an important regulator of cell growth whose constitutively active oncogenic counterpart, v-kit, induces sarcomas in cats. Mutations in murine c-kit that reduce the receptor tyrosine kinase activity cause deficiencies in the migration and proliferation of melanoblasts, hematopoietic stem cells, and primordial germ cells. We therefore investigated whether c-Kit regulates normal human melanocyte proliferation and plays a role in melanomas. We show that normal human melanocytes respond to mast cell growth factor (MGF), the Kit-ligand that stimulates phosphorylation of tyrosyl residues in c-Kit and induces sequential phosphorylation of tyrosyl residues in several other proteins. One of the phosphorylated intermediates in the signal transduction pathway was identified as an early response kinase (mitogen-activated protein [MAP] kinase). Dephosphorylation of a prominent 180-kDa protein suggests that MGF also activates a phosphotyrosine phosphatase. In contrast, MGF did not induce proliferation, the cascade of protein phosphorylations, or MAP kinase activation in the majority of cells cultured from primary nodular and metastatic melanomas that grow independently of exogenous factors. In the five out of eight human melanoma lines expressing c-kit mRNAs, c- Kit was not constitutively activated. Therefore, although c-Kit-kinase is a potent growth regulator of normal human melanocytes, its activity is not positively associated with malignant transformation.
This article has been cited by other articles:
![]() |
L. A. Fecher, S. D. Cummings, M. J. Keefe, and R. M. Alani Toward a Molecular Classification of Melanoma J. Clin. Oncol., April 20, 2007; 25(12): 1606 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. de Paulis, G. Minopoli, E. Arbustini, G. de Crescenzo, F. Dal Piaz, P. Pucci, T. Russo, and G. Marone Stem Cell Factor Is Localized in, Released from, and Cleaved by Human Mast Cells J. Immunol., September 1, 1999; 163(5): 2799 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Longley Jr., D. D. Metcalfe, M. Tharp, X. Wang, L. Tyrrell, S.-z. Lu, D. Heitjan, and Y. Ma Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis PNAS, February 16, 1999; 96(4): 1609 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Leslie, J. O'Prey, C. Bartholomew, and P. R. Harrison An Activating Mutation in the Kit Receptor Abolishes the Stroma Requirement for Growth of ELM Erythroleukemia Cells, But Does Not Prevent Their Differentiation in Response to Erythropoietin Blood, December 15, 1998; 92(12): 4798 - 4807. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chin, G. Merlino, and R. A. DePinho Malignant melanoma: modern black plague and genetic black box Genes & Dev., November 15, 1998; 12(22): 3467 - 3481. [Full Text] |
||||
![]() |
T. Kunisada, S.-Z. Lu, H. Yoshida, S. Nishikawa, S.-i. Nishikawa, M. Mizoguchi, S.-i. Hayashi, L. Tyrrell, D. A. Williams, X. Wang, et al. Murine Cutaneous Mastocytosis and Epidermal Melanocytosis Induced by Keratinocyte Expression of Transgenic Stem Cell Factor J. Exp. Med., May 18, 1998; 187(10): 1565 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sviderskaya, W. Wakeling, and D. Bennett A cloned, immortal line of murine melanoblasts inducible to differentiate to melanocytes Development, January 5, 1995; 121(5): 1547 - 1557. [Abstract] [PDF] |
||||
![]() |
B. J. Longley, G. S. Morganroth, L. Tyrrell, T. G. Ding, D. M. Anderson, D. E. Williams, and R. Halaban Altered Metabolism of Mast-Cell Growth Factor (c-kit Ligand) in Cutaneous Mastocytosis N. Engl. J. Med., May 6, 1993; 328(18): 1302 - 1307. [Abstract] [Full Text] |
||||